Rituximab, MABTHERA®, RITEMVIA®, RIXATHON® – in treatment of rheumatic diseases (PDF, 212.7 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Sarilumab, KEVZARA® – in treatment of rheumatic diseases (PDF, 208.24 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Scintigraphy of thyroid metastases (PDF, 112.84 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Secukinumab, COSENTYX ® – in treatment of rheumatic diseases (PDF, 210.74 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Sulfasalazine, SALAZOPYRIN EN® – in treatment of rheumatic diseases (PDF, 209.27 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Thyroid scintigraphy (PDF, 130.97 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Tocilizumab, ROACTEMRA® – in treatment of rheumatic diseases (PDF, 210.29 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Tofacitinib, Xeljanz® – in treatment of rheumatic diseases (PDF, 209.85 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|
Ustekinumab, STELARA ® – in treatment of rheumatic diseases (PDF, 208.18 KB) |
The Wellbeing Services County of Satakunta |
Finnish |
|